Načítá se...
Somatostatin and insulin mediate glucose-inhibited glucagon secretion in the pancreatic α-cell by lowering cAMP
The dysregulation of glucose-inhibited glucagon secretion from the pancreatic islet α-cell is a critical component of diabetes pathology and metabolic disease. We show a previously uncharacterized [Ca(2+)](i)-independent mechanism of glucagon suppression in human and murine pancreatic islets whereby...
Uloženo v:
| Vydáno v: | Am J Physiol Endocrinol Metab |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Physiological Society
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4297778/ https://ncbi.nlm.nih.gov/pubmed/25406263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00344.2014 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|